FierceBiotech 2026년 1월 8일 Lilly links up with InduPro in next-gen cancer treatment deal worth up to $950M
Endpoints News 2025년 12월 22일 Aktis Oncology files for IPO to fund Lilly-partnered radiopharma pipeline
BioPharma Dive 2025년 12월 18일 Lilly obesity pill, headed for quick FDA review, hits mark in ‘maintenance’ trial
Endpoints News 2025년 12월 18일 Lilly’s orforglipron is the first oral obesity therapy to show its worth in the maintenance setting
FierceBiotech 2025년 12월 11일 Lilly's obesity triple threat smashes efficacy expectations in phase 3 but proves intolerable for some
Endpoints News 2025년 12월 11일 Lilly’s triple agonist posts strongest weight loss data yet, unusual skin side effect also reported